Publications by authors named "Christophe Benvenuti"

Background: Transcatheter aortic valve implantation (TAVI) has become a first-line therapeutic option in patients with severe, symptomatic aortic stenosis at increased surgical risk. Despite its success, the TAVI procedure has been associated with acute life-threatening complications as myocardial infarction secondary to periprocedural coronary occlusion, annular rupture, or vascular injury.

Case Summary: A 79-year-old woman with a dysfunctional bioprosthetic valve following previous surgical valve replacement was hospitalized in our institution to perform a Valve-in-Valve Transcatheter Aortic Valve Replacement (ViV TAVR).

View Article and Find Full Text PDF
Article Synopsis
  • TAVI has become a popular treatment option for high-risk patients with severe aortic stenosis, and this study compared outcomes before and after its availability in a surgical institution.
  • The prevalence of high-risk patients increased significantly after TAVI was introduced, with 89% of these patients receiving TAVI in the modern era, whereas fewer received it before.
  • Although high-risk patients are now older and present with more advanced symptoms, their one-year survival rates are similar across both eras, indicating TAVI's impact but not necessarily improved survival outcomes within the first year.
View Article and Find Full Text PDF

Background And Aim Of The Study: Because valve replacement for aortic stenosis (AS) remains a difficult surgical challenge in the presence of left ventricular dysfunction, the immediate and long-term outcomes, and evolution of left ventricular ejection fraction (LVEF) in this setting, were analyzed.

Methods: Forty-three consecutive patients with severe AS (valve area < or =1 cm2) and reduced LVEF (< or =40%) who underwent valve replacement surgery at the authors' institution between April 1998 and December 2003 and were studied retrospectively.

Results: Preoperative characteristics included: LVEF 33 +/- 6%, mean transaortic pressure gradient 46 +/- 13 mmHg, and aortic valve area 0.

View Article and Find Full Text PDF